4
Clinical Trials associated with Yangyin Fuzheng Jiedu Prescription / SuspendedNot ApplicableIIT Clinical study of Fuzheng Jiedu prescription on immune escape of diffuse large B-cell lymphoma
Start Date09 Oct 2024 |
Sponsor / Collaborator- |
/ Unknown statusEarly Phase 1IIT Based on the Comprehensive Evaluation System of Platelet Count/Splenic Length-diameter Ratio to Explore the Efficacy of Yang Yin Fu Zheng Jie Du Therapy in Delaying the Progression of HBV Associated Hepatocellular Carcinoma
Clinical research of Yang Yin Fu Zheng Jie Du therapy in HBV associated Hepatocellular Carcinoma based on the platelet count/splenic length-diameter ratio.The purpose of this study is to establish the efficacy evaluation system combined with platelet/splenic length-diameter ratio, and to clarify the effect of this method on relieving hepatitis B cirrhosis and delaying the progression of Hepatocellular Carcinoma.
/ Unknown statusEarly Phase 1IIT Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia
Clinical research of Yang Yin Fu Zheng Jie Du therapy in HBV related hepatocellular carcinoma induced anemia. The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy for patients belong to HBV-HCC induced anemia.
100 Clinical Results associated with Yangyin Fuzheng Jiedu Prescription
100 Translational Medicine associated with Yangyin Fuzheng Jiedu Prescription
100 Patents (Medical) associated with Yangyin Fuzheng Jiedu Prescription
100 Deals associated with Yangyin Fuzheng Jiedu Prescription